Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108352 | 0.91 | TSHR (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL17108353 | 0.90 | TSHR (0.38) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12972095 | 0.88 | TSHR (0.39) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12313901 | 0.85 | TSHR (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL17108351 | 0.85 | TSHR (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL17612297 | 0.85 | SMN1; SMN2 (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL16663913 | 0.84 | TSHR (0.47) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL16675416 | 0.84 | TSHR (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL11408956 | 0.84 | TSHR (0.36) | TSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL14570593 | 0.84 | SMN1; SMN2 (0.39) | TSHRSMN1; SMN2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES (CN) | 2015-09-24 | — | — | US | disclosed |
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | CA1, PIEZO1, SLC9A1 | TSHR 3384/4885SMN1; SMN2 2854/4885ALDH1A1 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.